Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-111812

Co-Chief Executive Officer sold 18,589 shares at $3.20 ($59,429)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klee Justin B. Co-Chief Executive Officer 2024-09-30 Sale −18,589 $3.20 $59,429 3,120,569 D
Open-market sales · 18,589 sh · avg $3.20 · $59,429
Loading xslF345X05/ownership.xml…